Wentong Mei

685 total citations · 1 hit paper
24 papers, 470 citations indexed

About

Wentong Mei is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Wentong Mei has authored 24 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Wentong Mei's work include Pancreatitis Pathology and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Extracellular vesicles in disease (4 papers). Wentong Mei is often cited by papers focused on Pancreatitis Pathology and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Extracellular vesicles in disease (4 papers). Wentong Mei collaborates with scholars based in China, United States and Ethiopia. Wentong Mei's co-authors include Feng Cao, Jiongdi Lu, Yixuan Ding, Feng Cao, Zhen Fang, Liang Shang, Fei Li, Fei Li, Haichen Sun and Shuang Liu and has published in prestigious journals such as The American Journal of Gastroenterology, Experimental Cell Research and Cancer Letters.

In The Last Decade

Wentong Mei

22 papers receiving 465 citations

Hit Papers

Role of m6A writers, erasers and readers in cancer 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of m6A writers, erasers and readers in cancer
    2022 159 citations Zhen Fang, Wentong Mei et al. Experimental Hematology and Oncology profile →

Peers

Wentong Mei
Junhao Zheng China
Luhui Cai China
Wangwang Chen China
Erdong Shen China
Ping Qiang China
Lixin Wu China
Yanfeng Yin China
Shifeng Lou China
Yicong Shen China
Qingnuo Zeng China
Junhao Zheng China
Wentong Mei
Citations per year, relative to Wentong Mei Wentong Mei (= 1×) peers Junhao Zheng

Countries citing papers authored by Wentong Mei

Since Specialization
Citations

This map shows the geographic impact of Wentong Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentong Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentong Mei more than expected).

Fields of papers citing papers by Wentong Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wentong Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentong Mei. The network helps show where Wentong Mei may publish in the future.

Co-authorship network of co-authors of Wentong Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Wentong Mei. A scholar is included among the top collaborators of Wentong Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wentong Mei. Wentong Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Wentong, Yahui Ding, Chunjing Bian, et al.. (2025). The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinoma. Journal of Advanced Research.
2.
Jia, Yuchen, Jie Li, Wentong Mei, et al.. (2025). Pan-HDAC inhibitor LAQ824 inhibits the progression of pancreatic ductal adenocarcinoma and suppresses immune escape by promoting antigen presentation. International Immunopharmacology. 154. 114528–114528. 3 indexed citations
3.
Lu, Jiongdi, Zhe Wang, Wentong Mei, et al.. (2025). A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis. BMC Gastroenterology. 25(1). 374–374. 3 indexed citations
4.
Mei, Wentong, Xiuli Zhang, Mengya Niu, et al.. (2024). Deletion of myeloid-specific Orai1 calcium channel does not affect pancreatic tissue damage in experimental acute pancreatitis. Pancreatology. 24(4). 528–537. 2 indexed citations
5.
Liu, Yafang, Di Wu, Luyao Wang, et al.. (2024). A bHLH Transcription Factor Confers Salinity Stress Tolerance in Betula platyphylla. Plant Direct. 8(12). e70029–e70029.
6.
Mei, Wentong, Feng Cao, Jiongdi Lu, et al.. (2023). Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis. Frontiers in Endocrinology. 14. 1140873–1140873. 4 indexed citations
7.
Lu, Jiongdi, Zhi Zheng, Yixuan Ding, et al.. (2023). Characteristics and Incidence of Colon Complication in Necrotizing pancreatitis: A Propensity Score-Matched Study. Journal of Inflammation Research. Volume 16. 127–144. 1 indexed citations
8.
Lu, Jiongdi, Yixuan Ding, Wentong Mei, et al.. (2022). Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients. Infection and Drug Resistance. Volume 15. 7095–7106. 4 indexed citations
9.
Lu, Jiongdi, Feng Cao, Zhi Zheng, et al.. (2022). How to Identify the Indications for Early Intervention in Acute Necrotizing Pancreatitis Patients: A Long-Term Follow-Up Study. Frontiers in Surgery. 9. 842016–842016. 8 indexed citations
10.
Fang, Zhen, Wentong Mei, Jiongdi Lu, et al.. (2022). Role of m6A writers, erasers and readers in cancer. Experimental Hematology and Oncology. 11(1). 45–45. 159 indexed citations breakdown →
11.
12.
Ding, Yixuan, Jiongdi Lu, Yuchen Jia, et al.. (2022). Identification of key microRNAs in exosomes derived from patients with the severe acute pancreatitis. Asian Journal of Surgery. 46(1). 337–347. 8 indexed citations
13.
Jia, Yuchen, Yixuan Ding, Wentong Mei, et al.. (2021). Extracellular vesicles and pancreatitis: mechanisms, status and perspectives. International Journal of Biological Sciences. 17(2). 549–561. 22 indexed citations
14.
Zheng, Zhi, Jiongdi Lu, Yixuan Ding, et al.. (2021). Comparison of safety, efficacy, and long-term follow-up between “one-step” and “step-up” approaches for infected pancreatic necrosis. World Journal of Gastrointestinal Surgery. 13(11). 1372–1389. 1 indexed citations
15.
Jia, Yuchen, Yixuan Ding, Wentong Mei, et al.. (2021). Anterior abdominal abscess - a rare manifestation of severe acute pancreatitis: A case report. World Journal of Clinical Cases. 9(30). 9218–9227. 1 indexed citations
16.
Ding, Yixuan, Wentong Mei, Zhi Zheng, et al.. (2021). Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p. Tissue and Cell. 73. 101623–101623. 24 indexed citations
17.
Mei, Wentong, Feng Cao, & Fei Li. (2020). Two cases of agenesis of the dorsal pancreas and a review of the literature. BMC Gastroenterology. 20(1). 94–94. 12 indexed citations
18.
Mei, Wentong, Yixuan Ding, Shuo Wang, et al.. (2020). Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes. Journal of Cancer Research and Clinical Oncology. 146(11). 3049–3061. 13 indexed citations
19.
Ding, Yixuan, Feng Cao, Haichen Sun, et al.. (2018). Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Cancer Letters. 442. 351–361. 148 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junhao Zheng Breakdown of academic impact, for papers by Luhui Cai Breakdown of academic impact, for papers by Wangwang Chen Breakdown of academic impact, for papers by Erdong Shen Breakdown of academic impact, for papers by Ping Qiang Breakdown of academic impact, for papers by Lixin Wu Breakdown of academic impact, for papers by Yanfeng Yin Breakdown of academic impact, for papers by Shifeng Lou Breakdown of academic impact, for papers by Yicong Shen Breakdown of academic impact, for papers by Qingnuo Zeng
Rankless by CCL
2026